InvestorsHub Logo

AshvsEvilDead

09/06/18 1:25 PM

#18705 RE: boston745 #18703

CTL could get access but doesn't sound like exclusivity. Amedica is monetizing the biomaterial. It's only existing inventory and spine products inc (valeo, Taurus, preference) to CTL if I read it correctly.